The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-On the radar: Allianz, Richemont, RSA

Fri, 06th Nov 2020 07:42

Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

ON THE RADAR: ALLIANZ, RICHEMONT, RSA (0740 GMT)

European stocks are poised to open lower after a 5-day rally
as focus is back on the economic impact of the virus, while
investors are waiting for final results of the U.S. elections.

Yet, a batch of stronger than expected corporate results is
providing some support to European equities.

Allianz stocks are up 2.1% in premarket trade
after the company posted an unexpected 6% rise in net profit in
the third quarter, at 1.947 billion euros, higher than 1.626
billion euro consensus forecast.

Shares in Richemont are indicated up 4% as the
company sees a marked improvement in the second quarter thanks
to online retail sales and China. The Cartier jewellery maker's
net profit fell 82% in the six months to Sept. 30.

On the back of Richemont, Swatch shares are up 2.75%
in premarket trade.

Freenet, Rheinmetall and Deutsche
Telekom shares are up respectively 1.6%, 1.8% and
1.9% after results.

Bullish news also on the M&A front, with RSA Insurance Group
in talks with a consortium of Canadian insurer Intact
Financial and Danish insurer Tryg about a
possible break-up deal that values the British firm at about 7.2
billion pounds ($9.46 billion).

Shares in Bilfinger are up 9.8% in premarket trade
on a press report that the company decided to explore a sale
after receiving takeover interest.

British industrial software provider Aveva Group
intends to raise 2.84 billion pounds through a rights issue to
partly fund the acquisition of SoftBank-backed peer OSIsoft.

In the vaccine front, AstraZeneca plans to start
early and mid-stage clinical trials of its COVID-19 vaccine
candidate in China this year as it prepares a global rollout.

Novartis's canakinumab failed to help COVID-19
patients survive without invasive ventilation compared with
standard therapy, dashing hopes the arthritis drug could be
repurposed during the pandemic.

Seven municipalities in northern Denmark imposed a hard
lockdown, while Britain said it is removing Denmark
from the government's travel corridor list. Paris
will be placed under more restrictions, Greece
ordered a nationwide lockdown for three weeks.

As a result, British airline easyJet said it will
fly no more than 20% of capacity for the rest of the year.

(Stefano Rebaudo and Joice Alves)

*****

EUROPE IN THE RED AFTER 5-DAY WINNING STREAK (0633 GMT)

European stock futures are in the red along with their U.S.
peers after a 5-day rally, but an expected political gridlock in
the U.S. props up risk sentiment.

Investors have been betting on a Republican controlled
Senate that would block any moves to tighten regulation and
raise taxes.

But their focus is now back on the economic impact of new
lockdowns in Europe to contain the pandemic and a U.S. fiscal
stimulus which could be way smaller than expected.

In the battleground states of Georgia and Pensylvania there
is not a clear winner of the presidential elections yet.

(Stefano Rebaudo)

*****

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.